Eli Lilly and Co.
FDA approves Cymbalta for the treatment of depression
Published in Pharma Law Weekly, August 31st, 2004
Cymbalta, a balanced reuptake inhibitor of serotonin and norepinephrine, has been studied in more than 6,000 adults with major depression worldwide. Its approval gives healthcare professionals and patients a long-awaited new option for treating the broad range of emotional and physical symptoms of depression. Today, only 25-35% of patients treated for depression in clinical studies experience relief from all of their disease symptoms.
"Depression is a whole-body...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2004-08-31)
More Articles from Pharma Law Weekly
- Abbott Laboratories
Government decides not to intervene and force down AIDS drug price - Alnylam Pharmaceuticals, Inc.
Hybridon licenses key VEGF patents for treatment of ocular diseases - Alnylam Pharmaceuticals, Inc.
Pharmaceutical firm reports on IPO, financial results - Best Practices, LLC
Drug companies approach brand security issue head on, study shows - Business Update
Altria sees $25 million gain from accounting rule - Curis, Inc.
Company issued U.S. patent covering method for treating stroke - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
